VYNE - VYNE Therapeutics' (VYNE) CEO Dave Domzalski on Q1 2021 Results - Earnings Call Transcript
VYNE Therapeutics Inc. (VYNE) Q1 2021 Earnings Conference Call May 6, 2021 8:30 AM ET Company Participants Michael Wood – LifeSci Advisors Dave Domzalski – President and Chief Executive Officer Andrew Saik – Chief Financial Officer Matt Wiley – Chief Commercial Officer Conference Call Participants David Amsellem – Piper Sandler Carvey Leung – Cantor Fitzgerald Oren Livnat – H.C. Wainwright Patrick Dolezal – LifeSci Capital Presentation Operator Good morning and welcome to the VYNE Therapeutics Conference Call to Discuss the First Quarter 2021 Financial Results and Update. At this time all participants are in a listen-only mode. [Operator instructions] I will now turn the call over to Michael Wood of LifeSci Advisors. Please go ahead. Michael Wood Good morning, everyone, and thank you for joining us. Before we begin with formal remarks, let me remind you that some of the information in the press release issued this morning and on
For further details see:
VYNE Therapeutics' (VYNE) CEO Dave Domzalski on Q1 2021 Results - Earnings Call Transcript